79 related articles for article (PubMed ID: 19905989)
21. Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system.
Nayak UY; Shavi GV; Nayak Y; Averinen RK; Mutalik S; Reddy SM; Gupta PD; Udupa N
J Control Release; 2009 Jun; 136(2):125-31. PubMed ID: 19239918
[TBL] [Abstract][Full Text] [Related]
22. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of ocular drug delivery system.
Gorle AP; Gattani SG
Pharm Dev Technol; 2010; 15(1):46-52. PubMed ID: 19552545
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of an oral pulsatile delivery system for melatonin in humans.
Hoffmann H; Dittgen M; Hoffmann A; Bartsch C; Breitbarth H; Timpe C; Farker K; Schmidt U; Mellinger U; Zimmermann H; Gräser T; Oettel M
Pharmazie; 1998 Jul; 53(7):462-6. PubMed ID: 9699222
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.
Löbenberg R; Kim JS; Amidon GL
Eur J Pharm Biopharm; 2005 May; 60(1):17-23. PubMed ID: 15848051
[TBL] [Abstract][Full Text] [Related]
26. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system.
Bott C; Rudolph MW; Schneider AR; Schirrmacher S; Skalsky B; Petereit HU; Langguth P; Dressman JB; Stein J
Aliment Pharmacol Ther; 2004 Aug; 20(3):347-53. PubMed ID: 15274672
[TBL] [Abstract][Full Text] [Related]
27. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
Chen SJ; Zhu JB
Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
[TBL] [Abstract][Full Text] [Related]
28. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
29. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
30. Controlled release polymeric ocular delivery of acyclovir.
Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable polymers in controlled drug delivery.
Heller J
Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
[TBL] [Abstract][Full Text] [Related]
32. Oral pulsatile delivery systems based on swellable hydrophilic polymers.
Gazzaniga A; Palugan L; Foppoli A; Sangalli ME
Eur J Pharm Biopharm; 2008 Jan; 68(1):11-8. PubMed ID: 17888641
[TBL] [Abstract][Full Text] [Related]
33. In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension technique.
Mathir ZM; Dangor CM; Govender T; Chetty DJ
J Microencapsul; 1997; 14(6):743-51. PubMed ID: 9394255
[TBL] [Abstract][Full Text] [Related]
34. Influence of barium sulfate X-ray imaging contrast material on properties of floating drug delivery tablets.
Diós P; Szigeti K; Budán F; Pócsik M; Veres DS; Máthé D; Pál S; Dévay A; Nagy S
Eur J Pharm Sci; 2016 Dec; 95():46-53. PubMed ID: 27687639
[TBL] [Abstract][Full Text] [Related]
35. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
36. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
37. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
Fan TY; Wei SL; Yan WW; Ding WX
Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
[TBL] [Abstract][Full Text] [Related]
38. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
Asghar LF; Azeemuddin M; Jain V; Chandran S
Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology).
Sangalli ME; Maroni A; Busetti C; Zema L; Giordano F; Gazzaniga A
Boll Chim Farm; 1999 Mar; 138(3):68-73. PubMed ID: 10394705
[TBL] [Abstract][Full Text] [Related]
40. Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices.
Veiga F; Salsa T; Pina ME
Drug Dev Ind Pharm; 1998 Jan; 24(1):1-9. PubMed ID: 15605591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
